← Leaderboards
Joyce Marie Slingerland
Georgetown University
$12,812,016
Attributed
$13,878,601
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,878,601 · 10
By mechanism
R01$11,271,690 · 5
T32$1,390,296 · 1
R21$592,005 · 1
K12$476,346 · 1
P30$148,264 · 2
Top collaborators
- Barry Ian Hudson3 shared
- Mark Daniel Pegram2 shared
Most similar at Georgetown University
Same institution · by research overlap
- Alejandra Hurtado De Mendoza Casaus$3,088,220
- Martha Gay$814,845
- Vanessa B Sheppard$7,900,849
- Robert R. Clarke$13,679,896
- Barry Ian Hudson$770,583
Others in their field
Top investigators on “Grant”
- David R. Weir · University Of Michigan At Ann Arbor$373,949,788
- David Heimbrook · Leidos Biomedical Research, Inc.$341,196,902
- Eric S Lander · Whitehead Institute For Biomedical Res$323,181,457
- Jeffrey P Krischer · University Of South Florida$258,583,867
- Lawrence Corey · Fred Hutchinson Cancer Center$253,286,867
- Barton F Haynes · Duke University$243,251,908
Research focus
GrantMediatingTumorIn VivoMalignant NeoplasmsMalignant Breast NeoplasmTissuesSignal TransductionIn VitroLinkNew Therapeutic TargetGrowthGene ExpressionCellsTranscription FactorCancer Stem CellTumor ProgressionNeoplasm MetastasisEstrogensBreastInhibitor/AntagonistPreventCancer CellPhosphorylation
Grant awards (45)
Targeting RAGE in tumor and TME to oppose inflammation and drug resistance in obesity associated ER+ breast cancer$529,962
R01 · FY2025 · CA
Mechanistic Links Between Changing Estrogen Profiles, Inflammation and the Increased Risk and Metastasis of Breast Cancer in Obese Women$417,711
R01 · FY2025 · CA · contact PI
Cancer Host Interactions Program$42,129
P30 · FY2025 · CA · contact PI
Cancer Host Interactions Program$13,155
P30 · FY2025 · CA · contact PI
Novel roles for p27 as transcriptional co-regulator of cJun in stem cells and development$568,561
R01 · FY2024 · CA · contact PI
Targeting RAGE in tumor and TME to oppose inflammation and drug resistance in obesity associated ER+ breast cancer$494,656
R01 · FY2024 · CA
Mechanistic Links Between Changing Estrogen Profiles, Inflammation and the Increased Risk and Metastasis of Breast Cancer in Obese Women$395,178
R01 · FY2024 · CA · contact PI
Cancer Host Interactions Program$10,469
P30 · FY2024 · CA · contact PI
Novel roles for p27 as transcriptional co-regulator of cJun in stem cells and development$584,586
R01 · FY2023 · CA · contact PI
Targeting RAGE in tumor and TME to oppose inflammation and drug resistance in obesity associated ER+ breast cancer$516,548
R01 · FY2023 · CA
Mechanistic Links Between Changing Estrogen Profiles, Inflammation and the Increased Risk and Metastasis of Breast Cancer in Obese Women$415,197
R01 · FY2023 · CA · contact PI
Novel roles for p27 as transcriptional co-regulator of cJun in stem cells and development$577,061
R01 · FY2022 · CA · contact PI
Research Program - Breast Cancer$82,511
P30 · FY2022 · CA · contact PI
Novel roles for p27 as transcriptional co-regulator of cJun in stem cells and development$588,831
R01 · FY2021 · CA · contact PI
Mechanistic Links Between Changing Estrogen Profiles, Inflammation and the Increased Risk and Metastasis of Breast Cancer in Obese Women$351,133
R01 · FY2021 · CA · contact PI
Novel roles for p27 as transcriptional co-regulator of cJun in stem cells and development$595,229
R01 · FY2020 · CA · contact PI
Mechanistic Links Between Changing Estrogen Profiles, Inflammation and the Increased Risk and Metastasis of Breast Cancer in Obese Women$277,287
R01 · FY2020 · CA · contact PI
Mechanistic Links Between Changing Estrogen Profiles, Inflammation and the Increased Risk and Metastasis of Breast Cancer in Obese Women$73,844
R01 · FY2020 · CA · contact PI
UM Calabresi Clinical Oncology Research Career Development Award$422,346
K12 · FY2019 · CA · contact PI
Mechanistic Links Between Changing Estrogen Profiles, Inflammation and the Increased Risk and Metastasis of Breast Cancer in Obese Women$340,596
R01 · FY2019 · CA · contact PI
Mechanistic Links Between Changing Estrogen Profiles, Inflammation and the Increased Risk and Metastasis of Breast Cancer in Obese Women$351,131
R01 · FY2018 · CA · contact PI
Effects of estrogen profiles and obesity on ER positive breat cancer PDX generation$125,000
R01 · FY2018 · CA · contact PI
UM Calabresi Clinical Oncology Research Career Development Award$54,000
K12 · FY2018 · CA · contact PI
Mechanistic Links Between Changing Estrogen Profiles, Inflammation and the Increased Risk and Metastasis of Breast Cancer in Obese Women$351,131
R01 · FY2017 · CA · contact PI
Effects of the PI3K Pathway on p27 Function and Cancer Progression$230,573
R01 · FY2014 · CA · contact PI
Mechanisms Whereby Src Activates Estrogen Stimulated ER Proteolysis and ER Target$275,640
R01 · FY2013 · CA · contact PI
Effects of the PI3K Pathway on p27 Function and Cancer Progression$223,441
R01 · FY2013 · CA · contact PI
Mechanisms Whereby Src Activates Estrogen Stimulated ER Proteolysis and ER Target$302,766
R01 · FY2012 · CA · contact PI
Effects of the PI3K Pathway on p27 Function and Cancer Progression$237,704
R01 · FY2012 · CA · contact PI
Mechanisms Whereby Src Activates Estrogen Stimulated ER Proteolysis and ER Target$312,687
R01 · FY2011 · CA · contact PI
Training in Translational Breast Cancer Research$293,035
T32 · FY2011 · CA · contact PI
Effects of the PI3K Pathway on p27 Function and Cancer Progression$237,704
R01 · FY2011 · CA · contact PI
Mechanisms Whereby Src Activates Estrogen Stimulated ER Proteolysis and ER Target$332,894
R01 · FY2010 · CA · contact PI
A Neoadjuvant Trial of Anastrazole and A Novel SRC Inhibitor, AZD0530, for LABC$297,018
R21 · FY2010 · CA · contact PI
Training in Translational Breast Cancer Research$285,916
T32 · FY2010 · CA · contact PI
Effects of the PI3K Pathway on p27 Function and Cancer Progression$245,056
R01 · FY2010 · CA · contact PI
Mechanisms Whereby Src Activates Estrogen Stimulated ER Proteolysis and ER Target$344,456
R01 · FY2009 · CA · contact PI
Training in Translational Breast Cancer Research$298,148
T32 · FY2009 · CA · contact PI
A Neoadjuvant Trial of Anastrazole and A Novel SRC Inhibitor, AZD0530, for LABC$294,987
R21 · FY2009 · CA · contact PI
Training in Translational Breast Cancer Research$342,131
T32 · FY2008 · CA · contact PI
PI3K opposes p27 and G1 arrest by TGF-B in human cancer$235,586
R01 · FY2007 · CA · contact PI
Training in Translational Breast Cancer Research$171,066
T32 · FY2007 · CA · contact PI
PI3K opposes p27 and G1 arrest by TGF-B in human cancer$242,621
R01 · FY2006 · CA · contact PI
PI3K opposes p27 and G1 arrest by TGF-B in human cancer$248,460
R01 · FY2005 · CA
PI3K opposes p27 and G1 arrest by TGF-B in human cancer$248,460
R01 · FY2004 · CA